Skip to content

    Immunovant (IMVT) stock price & financials

    View IMVT earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+171.4% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    Operating Profit
    Net Profit
    -$109.12M
    -$111.12M
    -$106.45M
    -$120.61M
    -$126.50M
    -15.9%
    -$110.64M
    +0.4%
    -$147.86M
    -38.9%
    -$153.22M
    -27.0%
    Weakening
    EPS
    $-0.74
    $-0.76
    $-0.71
    $-0.73
    +1.4%
    $-0.61
    +19.7%
    $-0.75
    -5.6%
    Strengthening
    Other Income
    Interest
    Depreciation
    Profit before Tax
    -$109.04M
    -$110.97M
    -$105.86M
    -$119.70M
    -$125.91M
    -15.5%
    -$109.08M
    +1.7%
    -$150.70M
    -42.4%
    -$153.22M
    -28.0%
    Weakening
    MarginsOPM
    Tax
    -0.1%
    -0.1%
    -0.6%
    -0.8%
    -0.5%
    -571.4%
    -1.4%
    -914.3%
    1.9%
    0.0%
    +100.0%
    Weakening
    ReturnsROIC
    5.7%
    5.9%
    5.6%
    6.4%
    6.7%
    +15.9%
    5.8%
    -0.4%
    7.8%
    +38.9%
    8.1%
    +27.0%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY19FY20FY21FY22FY23FY24FY25FY26TTM
    AssetsCash & Equivalents$6.99M$100.57M$400.15M$493.82M$376.53M$635.37M$713.97M$902.11M$797.80M
    Short-Term Investments
    Total Current Assets$12.58M$109.08M$409.01M$512.93M$404.33M$665.77M$767.66M$948.82M$851.18M
    Net PP&E$54.0K$65.0K$3.48M$2.63M$1.50M$595.0K$942.0K$515.0K$351.0K
    Goodwill
    Intangibles
    Total Assets$13.83M$109.39M$412.49M$515.56M$405.84M$666.37M$776.22M$957.01M$852.49M
    LiabilitiesTotal Current Liabilities$300.4K$15.32M$18.77M$44.52M$43.30M$48.61M$68.78M$104.42M$117.10M
    Short-Term Debt
    Long-Term Debt
    Long-Term Leases$0$2.24M$1.22M$47.0K$0
    Total Liabilities$6.49M$15.32M$21.01M$45.74M$43.34M$48.61M$68.78M$104.42M$117.10M
    EquityCommon Stock & APIC$4.0K$5.0K$10.0K$12.0K$13.0K$14.0K$16.0K$20.0K$20.0K
    Retained Earnings-$24.84M-$91.23M-$198.66M-$355.39M-$566.35M-$825.68M-$1.24B-$1.75B-$1.90B
    Total Equity$7.34M$94.07M$391.48M$469.82M$362.49M$617.76M$707.45M$852.59M$735.39M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY19FY20FY21FY22FY23FY24FY25FY26TTM
    ActivitiesCash from Operating-$28.55M-$53.36M-$83.33M-$106.11M-$188.19M-$214.23M-$375.87M-$407.31M-$414.30M
    Cash from Investing-$52.0K-$31.0K-$210.0K-$254.0K-$197.0K-$360.0K-$759.0K-$8.0K
    Cash from Financing$35.58M$146.97M$383.11M$200.13M$70.89M$472.43M$454.49M$595.76M$612.93M
    SummaryCapital Expenditure-$52.0K-$31.0K-$210.0K-$254.0K-$197.0K-$360.0K-$759.0K-$8.0K
    Free Cash Flow-$28.60M-$53.39M-$83.54M-$106.37M-$188.39M-$214.59M-$376.63M-$407.32M
    FCF Margin

    Ratios